For Injectable Drugs Wireless Connectivity Allows Caregivers to Manage Patients on an Exception Basis

(Amherst, NH) – The growing emphasis on drug self-administration is having a major impact on the pharmaceutical industry. The aging population and managed care initiatives are major forces driving the growth of home healthcare, a trend that includes the self-administration of drug therapies for chronic conditions such as diabetes, arthritis and hormone replacement therapy. This trend is creating an increased demand for medical devices that are patient-friendly and cost-effective.

Much of the activity surrounding connected drug injection devices is focused on chronic diseases – conditions where the ability of caregivers to access data on patient self-administration activities, patient reported outcomes, and feedback on the user experience can yield significant benefits in patient Quality of Life.

For chronic conditions adherence has a direct effect on the patient’s quality-of-life. Connected devices – drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs – are gaining interest among industry and managed care participants.

As the industry debates ways to adapt to these and similar issues that are associated with patient self-medication, wirelessly enabled devices – drug injection devices that are designed to address the patient adherence issue by issuing reminders and recording data about patient dosing activity and making it available to healthcare providers (HCPs) – are gaining interest among industry and managed care participants.

The success of most medical devices is closely linked to user-interface design. This is particularly true in cases where there is substantial market competition and the associated technology has more or less matured, making user-interface quality a prominent factor in product differentiation. The safety of most medical devices is also closely linked to user-interface quality, because design shortcomings may lead directly or indirectly to use errors, with severe consequences that can include patient injury and death. Medical device user-interface designers, while dealing with technological limitations, incomplete understanding of user needs, and aesthetic decisions, look beyond core design attributes.

Data security is an umbrella term that covers numerous methods in which data sent over a wireless connection can be compromised. Data privacy, data theft and data manipulation are just a few of these. While this is an ongoing concern in the healthcare space, because the current generation of connected devices utilize passive, low power wireless protocols, the dangers related to security are less than that associated with everyday types of wireless data transmission.

Connected drug delivery devices are detailed in a new and comprehensive report researched and written by Greystone Research Associates. Connected Drug Injection Devices to 2024: Devices, Products, Markets, Strategies and Forecasts analyzes the global market for connected injection devices. The report includes analysis of enabling wireless technologies, marketed and development-stage devices, demand drivers, development factors, market considerations, and strategic and economic factors, and provides profiles of market sector participants.

More information is available at http://www.greystoneassociates.org



Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.